Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
255.17
+1.40 (0.55%)
At close: Jun 12, 2026, 4:00 PM EDT
257.90
+2.73 (1.07%)
After-hours: Jun 12, 2026, 7:49 PM EDT
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $13.13 billion as of June 12, 2026. Its market cap has increased by 154.87% in one year.
Market Cap
13.13B
Enterprise Value
13.05B
1-Year Change
154.87%
Ranking
Category
Stock Price
$255.17
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $13.13B, an increase of 8,377.07%. That is a compound annual growth rate of 52.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 13.13B | 42.61% |
| Dec 31, 2025 | 9.21B | 124.55% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
| Nov 19, 2015 | 154.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 15.30B |
| Jazz Pharmaceuticals | 14.82B |
| Exelixis | 13.45B |
| Ascendis Pharma | 13.39B |
| BridgeBio Pharma | 13.23B |
| Ionis Pharmaceuticals | 12.20B |
| Madrigal Pharmaceuticals | 10.93B |
| BioMarin Pharmaceutical | 10.74B |